# A phase3 Study Measuring the Effect of Rosuvastatin 20 mg on Carotid Intima-Media Thickness in Chinese Subjects With Subclinical Atherosclerosis

Study · id `cardio:ct-nct02546323` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02546323](<https://clinicaltrials.gov/study/NCT02546323>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02546323

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 543 participants.

## Technical summary

Registry record NCT02546323. Randomized; quadruple masking; primary purpose treatment. Start 2015-09-17 (actual); primary completion 2019-01-29 (actual). Results posted on 2019-12-11.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 543 participants (enrolled count; ClinicalTrials.gov record NCT02546323, source copy `cardio:ctgov-nct02546323-2019-12-11`, retrieved 2026-10-31)
- Started: 2015-09-17 (actual) (ClinicalTrials.gov record NCT02546323, source copy `cardio:ctgov-nct02546323-2019-12-11`, retrieved 2026-10-31)
- Primary completion: 2019-01-29 (actual) (ClinicalTrials.gov record NCT02546323, source copy `cardio:ctgov-nct02546323-2019-12-11`, retrieved 2026-10-31)
- Completion: 2019-01-29 (actual) (ClinicalTrials.gov record NCT02546323, source copy `cardio:ctgov-nct02546323-2019-12-11`, retrieved 2026-10-31)
- Results first posted: 2019-12-11 (ClinicalTrials.gov record NCT02546323, source copy `cardio:ctgov-nct02546323-2019-12-11`, retrieved 2026-10-31)
- Countries: China (ClinicalTrials.gov record NCT02546323, source copy `cardio:ctgov-nct02546323-2019-12-11`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02546323-2019-12-11`, retrieved 2026-10-31)

## The registry's words

- Brief title: A phase3 Study Measuring the Effect of Rosuvastatin 20 mg on Carotid Intima-Media Thickness in Chinese Subjects With Subclinical Atherosclerosis
- Condition: Atherosclerosis
- Intervention (Drug): Rosuvastatin
- Intervention (Drug): Placebo
- Lead sponsor: AstraZeneca
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Atherosclerosis (`cardio:atherosclerosis`)
- Registry intervention name matches this record: Rosuvastatin (`cardio:rosuvastatin`)
- Registry intervention is a member of this class by a sourced record link: Statins (`cardio:statins`)
- Registry lists this organization as the lead sponsor: AstraZeneca (`cardio:astrazeneca`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Rosuvastatin Slows Progression of Carotid Intima-Media Thickness: The METEOR-China Randomized Controlled Study (`cardio:pubmed-36017704`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 32e7d1e0fc60bb66922923da0e7ed511af81626520a93664f9e6e36325d88fca
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
